Sam Rockwell’s latest film, Good Luck, Have Fun, Don’t Die, is currently killing it with critics, sitting pretty at a 94% on the Rotten Tomatoes Tomatometer, and earning him some pretty high praise ...

Chicago Fire got off to a harrowing start in the 2026 TV schedule in the wake of the fall finale cliffhanger than ended with Severide and Van Meter in grave danger. Severide managed to escape the ...

South Side Charter School, seen on Monday, is housed on the property of St. Joan of Arc Church in south Minneapolis. When it comes to staying informed in Minnesota, our newsletters overdeliver.

As generative artificial intelligence is incorporated into medical device technologies, there are undoubtedly going to be questions. What are the safety measures that should be enacted? Are there any ...

Nicole Sganga is CBS News' homeland security and justice correspondent. She is based in Washington, D.C., and reports for all shows and platforms. The Immigration and Customs Enforcement agent who ...

The family of Renee Good is planning to release a statement about the deadly shooting that happened in Minneapolis on Wednesday. Good was shot and killed by an ICE agent near 34th Street and Portland ...

Minneapolis Public Schools is allowing remote learning for the next month, claiming some parents are afraid ICE officers might apprehend them when they drop off or pick up their children. Schools were ...

The Minneapolis school system announced Thursday it will offer remote learning for a month as tensions escalate in the city after a federal officer shot and killed a woman this week. In an email ...

My home state of Minnesota, a beautiful place full of hardworking, kind people, continues to be at the center of the national spotlight − and not for those good reasons. This time, it is due to the ...

The phrase “The Good, the Bad and the Ugly” isn’t just the title of a popular movie released in 1966 starring Clint Eastwood. It’s a description of what all history books must include if they’re to ...

Three months after reporting a win in a phase 3 trial of its kidney transplant drug imlifidase—which is likely to pave the way for a first-time approval in the U.S.—Hansa Biopharma has stumbled in a ...